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basal; ** p<.05 vs cytokine without S; #p<.05 vs S+TNF or S+IL. In conclusion, at clini-
cally achievable concentrations S inhibits iNOS expression by inhibiting geranyl-gerany-
lation of a protein controlling iNOS expression. Such effect may contribute to
cardioprotection against excess NO production.
Noon
1116-35 Histopathological Study of Left Atrial Appendage 
Obtained at the Operation for Atrial Fibrillation
Tsunenori Saito, Daisuke Uchida, Tomonari Saito, Koichi Tamura, Yuichi Sugisaki, 
Nippon Medical School, Tokyo, Japan
Background: Surgical procedure for atrial fibrillation (AF) is an effective treatment. Patho-
logical changes of resected left atrial appendages (LAA) have not been studied. The cor-
relation between histological changes of LAA and clinical features of AF was evaluated.
Also, we investigated whether histological assessments of LAA prospect the recurrence
after the operation for AF.
Methods: Clinicopathological studies were made on 53 AF cases (49 biopsies and 4
autopsies: 46 - 83 years; 51 with and 2 without valvular disease) and 39 control autopsy
cases with sinus rhythm (5 with and 34 without valvular disease, 42 - 86 years). Together
with histopathological examination, cell size, nuclear size and shape, and % fibrosis in
LAA were evaluated using NIH image system. Histological findings were compared with
clinical features, including left atrial dimension (LAD), pulmonary capillary wedge pres-
sure, duration of clinical history of AF and that of basal diseases, and cardiac rhythm
after the operation. Results were analyzed by Chi square test or Fisher’s exact method.
Results: The partial disarray of cardiomyocytes was recognized in both AF and control
groups. Compared with control, LAA with AF showed hypertrophy of cardiomyocytes (p <
0.001), nuclear enlargement (p < 0.001), bizarre nuclear shape (BN) (p < 0.001), and
intercellular fibrosis (ICF) (p < 0.001) . Long clinical history (> 10 years) of AF resulted in
larger number of BN (p < 0.025) and more extensive ICF (p < 0.05). The patients with
larger LAD had more extensive ICF (p < 0.05). Among AF group, cases with mitral steno-
sis had larger cell size (p < 0.025) and more extensive ICF (p < 0.001) than those with
other valvular disease. Cases with recurrent AF after the operation had more cellular
hypertrophy (p < 0.01), nuclear enlargement (p < 0.01), BN (p < 0.01), and ICF (p < 0.01)
than others.
Conclusion: The histopathological findings of LAA reflect basal diseases and the duration
of AF. However, recurrence of AF after the operation is thought to be predictable from the
histological findings of bizarre nuclear shape and extensive intercellular fibrosis in LAA.
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1116-36 Prognostic Implications of Nonsustained Ventricular 
Tachycardia Early After ST Elevation Myocardial 
Infarction Treated With Fibrinolysis or Primary 
Angioplasty
Dan E. Hofsten, Kenneth Egstrup, Birgit Lund, Henning Molgaard, for the DANAMI-2 
investigators, Svendborg Hospital, Svendborg, Denmark, Skejby Sygehus, Aarhus 
University Hospital, Aarhus, Denmark
Background: The prognostic features of nonsustained ventricular tachycardia (nsVT)
detected on Holter monitoring after ST-segment elevation myocardial infarction (STEMI)
treated with primary angioplasty (PA) remains uncertain. We compared the prevalence
and prognostic implications of nsVT detected early after STEMI treated with either fibrin-
olysis or PA.
Methods: Twenty four hour Holter monitoring was initiated at discharge from STEMI in
1,157 patients who had been randomized to immediate revascularization with either
fibrinolysis (n = 575) or PA (n = 582) as part of the DANAMI-2 study. The definition of
nsVT was > 3 consecutive ventricular premature beats with an RR interval < 600 ms. Fol-
low-up ranged from 2 to 5 years. Primary end point was all-cause mortality.
Results: The incidence of nsVT was 9.4% in both treatment groups (p = 0.97). Univari-
ate analyses showed a significantly increased mortality associated with nsVT in fibrinoly-
sed patients (hazard ratio: 3.2; p < 0.001), but only a smaller, and non-significant, trend in
the PA group (hazard ratio: 2.2; p = 0.085).
In a stepwise multivariate Cox regression analysis incorporating clinical and investiga-
tional variables, nsVT was independently correlated to outcome after fibrinolysis (p =
0.025) but not after PA (p = 0.64).
Conclusion: The use of PA in STEMI does not affect the subsequent incidence of nsVT
as compared to fibrinolysis. However, unlike in fibrinolysed patients, nsVT is not an inde-
pendent predictor of outcome after primary angioplasty.
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1116-37 Use of the Implantable Loop Recorder in the Diagnosis 
and Management of Syncope: Long-Term Follow-Up
David J. Farwell, Nick Freemantle, Neil Sulke, Eastbourne General Hospital, Eastbourne, 
United Kingdom
Background: Implantable loop recorders (ILR) provide an opportunity to record ECG
data from a spontaneous syncopal event. We conducted a randomised study to investi-
gate the impact of the Reveal Plus ILR on an unselected population of patients with
recurrent syncope. Initial follow-up (reported ACC 2002) failed to demonstrate a reduc-
tion in syncopal events or an improvement in quality of life. We continued follow-up for a
further year in all patients.
Methods: All patients presenting acutely with recurrent unexplained syncope over a 16-
month period, following a basic clinical work up, were randomised to receive the ILR or
conventional investigation.
Results: 421 patients presented, 201 were eligible, median age 74 (IQ range 61-81)
54% female, with median syncopes 3 (IQ range 2-6). Median follow up 17 months (IQ
range 9-23). There were no significant differences between groups at randomisation.
42% of ILR patients and 8% of conventional patients received an ECG diagnosis (Hazard
ratio 4.9 95%CI 2.3-12.1). Time to 2nd syncope was increased in ILR patients (Hazard
ratio 2.2 95%CI 1.2-4.2). A greater variety of diagnoses and treatments were seen in ILR
patients. ILR patients had fewer post randomisation investigations and fewer days in hos-
pital, however cost savings were not statistically significant. There was a trend towards
improved quality of life in the ILR group with significant increase in visual/ analogue
scale/scores (p=0.033), no change was noted in SF-12 scores. Overall mortality was
12% with no difference between groups.
Conclusions: Investigation by ILR significantly increases the number of diagnoses and
treatments available to a typical syncopal population. Long-term follow up shows reduc-
tion in syncopal events with improved quality of life in patients investigated with an ILR.
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1116-38 Selection of Optimal Electrocardiographic Criteria for 
Detection of Unrecognized Myocardial Infarction: A 
Population Based Study
Khawaja A. Ammar, Barbara P. Yawn, Jan A. Kors, Steven Jacobsen, Lynn Urban, 
Douglas Mahoney, Richard J. Rodeheffer, Mayo Clinic, Rochester, MN, Olmsted Medical 
Center, Rochester, MN
Background: Unrecognized Myocardial Infarctions (UMIs) are fairly common and have a
prognosis similar to that of acute recognized myocardial infarctions. Surveillance electro-
cardiograms in population-based studies identify UMI. It has been shown that the wide
variation in UMI prevalence (20 to 44% of all MI) may be due to variations in ECG-MI cri-
teria used in various studies. We sought to find the best possible ECG criteria for detec-
tion of UMI, since it has both individual and public health implications. To the best of our
knowledge, this goal has never been undertaken before.
Methods: A random sample of 4203 out of 106400 Olmsted County residents, >45 years
of age were invited to participate. 2042 completed the survey consisting of detailed his-
tory, physical exam, medical record abstraction, ECG and echocardiogram. Six different
ECG-MI criteria (from different published studies), all based on Minnesota Code, were
applied to the same survey ECG and UMI prevalence was estimated. The operating test
characteristics of different criteria were compared against the gold standard of either a
documented, hospitalized MI or an MI confirmed by presence of regional wall motion
abnormalites by echocardiogram.
Results: The UMI proportion, relative to all myocardial infarctions, varied from 29% to
60%. The sensitivity and specificity of different ECG criteria varied between 19% to 32%
and 92% to 98% respectively, with multiple statistically significant differences (p values of
0.0001). The specificity improved with increasing width and height of Q waves, wheras
the sensitivity was enhanced by step-wise inclusion of minor Q, and major ST or T wave
abnormality, at the incremental cost of specificity. Enhancing the diagnostic performance
of ECG by exclusion of poor R wave progression as a criterion for ECG-MI, in patients
with severe emphysema or severe obesity, did not make a difference.
Conclusions: In our study, the best performance was displayed by ECG criteria used in
the Cardiovascular Health Study, with a near maximum sensitivity and specificity of 26%
and 96%, respectively. These incorporated major Q-waves as stand alone, and minor Q
waves only if accompanied by concomitant ST and T wave abnormalites.
iNOS protein expression (arbitrary densitometric units), expressed as mean ± SD, 
n=3 experiments
basal (untreated cells) 34±5 basal (untreated cells) 45±4
IL 160± 5* TNF 120±9*
IL+S 10-8 71±5** TNF+S 10-8 65±18**
IL+S108+ Mev 56±8 TNF+S 10-8 + Mev 77±10
IL+S 10-7 42±10** TNF+S 10-7 48±13**
IL+S 10-7 + Mev 106±10# TNF+S 10-7 + Mev 105±8#
IL+S 10-6 20±4** TNF+S 10-6 33±3**
IL+S 10-6 + Mev 131±14# TNF+S 10-6 + Mev 75±8#
